HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.

Abstract
The final pathway of beta cell destruction leading to insulin deficiency, hyperglycemia, and clinical type 1 diabetes is unknown. Here we show that circulating CTLs can kill beta cells via recognition of a glucose-regulated epitope. First, we identified 2 naturally processed epitopes from the human preproinsulin signal peptide by elution from HLA-A2 (specifically, the protein encoded by the A*0201 allele) molecules. Processing of these was unconventional, requiring neither the proteasome nor transporter associated with processing (TAP). However, both epitopes were major targets for circulating effector CD8+ T cells from HLA-A2+ patients with type 1 diabetes. Moreover, cloned preproinsulin signal peptide-specific CD8+ T cells killed human beta cells in vitro. Critically, at high glucose concentration, beta cell presentation of preproinsulin signal epitope increased, as did CTL killing. This study provides direct evidence that autoreactive CTLs are present in the circulation of patients with type 1 diabetes and that they can kill human beta cells. These results also identify a mechanism of self-antigen presentation that is under pathophysiological regulation and could expose insulin-producing beta cells to increasing cytotoxicity at the later stages of the development of clinical diabetes. Our findings suggest that autoreactive CTLs are important targets for immune-based interventions in type 1 diabetes and argue for early, aggressive insulin therapy to preserve remaining beta cells.
AuthorsAnia Skowera, Richard J Ellis, Ruben Varela-Calviño, Sefina Arif, Guo Cai Huang, Cassie Van-Krinks, Anna Zaremba, Chloe Rackham, Jennifer S Allen, Timothy I M Tree, Min Zhao, Colin M Dayan, Andrew K Sewell, Wendy W Unger, Wendy Unger, Jan W Drijfhout, Ferry Ossendorp, Bart O Roep, Mark Peakman
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 118 Issue 10 Pg. 3390-402 (Oct 2008) ISSN: 0021-9738 [Print] United States
PMID18802479 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Epitopes, T-Lymphocyte
  • Insulin
  • Protein Precursors
  • Protein Sorting Signals
  • preproinsulin
  • Glucose
Topics
  • Adolescent
  • Adult
  • CD8-Positive T-Lymphocytes (immunology)
  • Diabetes Mellitus, Type 1 (immunology, pathology)
  • Epitopes, T-Lymphocyte (drug effects, immunology)
  • Female
  • Glucose (metabolism, pharmacology)
  • Humans
  • Insulin (immunology, metabolism)
  • Insulin-Secreting Cells (pathology)
  • K562 Cells
  • Male
  • Phenotype
  • Protein Precursors (immunology, metabolism)
  • Protein Sorting Signals

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: